Iman Osman
Impact in
- Oncology top 0.2%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Oncology 164
- Cutaneous Melanoma Detection and Management 78
- Cancer Immunotherapy and Biomarkers 55
- CAR-T cell therapy research 32
-
- Melanoma and MAPK Pathways 63
- Co-authors
- David Polsky (65 shared papers)Anna C. Pavlick (78 shared papers)Eva Hernando (44 shared papers)Farbod Darvishian (56 shared papers)Richard L. Shapiro (72 shared papers)Russell S. Berman (67 shared papers)Nina Bhardwaj (17 shared papers)Douglas Hanniford (20 shared papers)
- Journals
- Journal of Clinical Oncology (46 papers)Clinical Cancer Research (20 papers)Journal of Translational Medicine (18 papers)Cancer (12 papers)Cancer Research (11 papers)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Iman Osman
254 papers receiving 12.3k citations
Iman Osman's Hit Papers
Peers
Comparison fields: 5 of 145
- Oncology 5.9k
- Cancer Research 3.0k
- Molecular Biology 7.5k
- Immunology 2.3k
- Pulmonary and Respiratory Medicine 1.8k
Countries citing papers authored by Iman Osman
This map shows the geographic impact of Iman Osman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iman Osman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iman Osman more than expected).
Fields of papers citing papers by Iman Osman
This network shows the impact of papers produced by Iman Osman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iman Osman. The network helps show where Iman Osman may publish in the future.
Co-authors
The 25 scholars most cited alongside Iman Osman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 265 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | BRAF mutation predicts sensitivity to MEK inhibition Hit paper breakdown → | 2005 | 1013 |
| 2 | 2009 | 451 | |
| 3 | 2004 | 407 | |
| 4 | 2014 | 315 | |
| 5 | 2010 | 297 | |
| 6 | 2011 | 292 | |
| 7 | 2009 | 290 | |
| 8 | 2017 | 238 | |
| 9 | 2020 | 237 | |
| 10 | Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment Hit paper breakdown → | 2022 | 235 |
| 11 | 2017 | 234 | |
| 12 | 2012 | 212 | |
| 13 | 2011 | 211 | |
| 14 | Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. | 2000 | 184 |
| 15 | 2013 | 184 | |
| 16 | 2013 | 178 | |
| 17 | 2010 | 173 | |
| 18 | Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues. | 2003 | 170 |
| 19 | 2019 | 159 | |
| 20 | 2021 | 152 |
About Iman Osman
Iman Osman is a scholar working on Oncology, Molecular Biology, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 265 papers that have together received 12.5k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (78 papers), Melanoma and MAPK Pathways (63 papers), Cancer Immunotherapy and Biomarkers (55 papers), Immunotherapy and Immune Responses (38 papers), Cancer Genomics and Diagnostics (35 papers), CAR-T cell therapy research (32 papers), MicroRNA in disease regulation (20 papers) and Prostate Cancer Treatment and Research (18 papers). The work is most often cited by research in Oncology (5.9k citations), Cancer Research (3.0k citations), Molecular Biology (7.5k citations), Immunology (2.3k citations) and Pulmonary and Respiratory Medicine (1.8k citations). Iman Osman has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include David Polsky, Anna C. Pavlick, Eva Hernando, Farbod Darvishian, Richard L. Shapiro, Russell S. Berman, Nina Bhardwaj, Douglas Hanniford, Judy Zhong and Howard I. Scher. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Journal of Translational Medicine, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.